Zinc-finger nucleases as a novel therapeutic strategy for targeting hepatitis B virus DNAs

Selective extraction of polyoma DNA from infected mouse cell cultures

Hirt, B. (1967) · Journal of Molecular Biology · doi:10.1016/0022-2836(67)90307-5 · Cited by 5,294 · see citing works

Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain.

Kim, Y. G., Cha, J., & Chandrasegaran, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1156 · Cited by 2,099 · see citing works

Zinc Finger-DNA Recognition: Crystal Structure of a Zif268-DNA Complex at 2.1 Å

Pavletich, N. P., & Pabo, C. O. (1991) · Science · doi:10.1126/science.2028256 · Cited by 2,081 · see citing works

Highly efficient endogenous human gene correction using designed zinc-finger nucleases

Urnov, F. D., Miller, J. C., Lee, Y.-L., Beausejour, C. M., Rock, J. M., Augustus, S., Jamieson, A. C., Porteus, M. H., Gregory, P. D., & Holmes, M. C. (2005) · Nature · doi:10.1038/nature03556 · Cited by 1,642 · see citing works

Lamivudine as Initial Treatment for Chronic Hepatitis B in the United States

Dienstag, J. L., Schiff, E. R., Wright, T. L., Perrillo, R. P., Hann, H.-W. L., Goodman, Z. D., Crowther, L., Condreay, L. D., Woessner, M. A., Rubin, M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910213411702 · Cited by 1,240 · see citing works

LAMIVUDINE AS INITIAL TREATMENT FOR CHRONIC HEPATITIS B IN THE UNITED STATES

Ules, J., Ienstag, L. D., Chiff, E. U. R. S., Right, L. W., Errillo, R. O. P. P., Ann, L. H., Rowther, L. Y. C., Ondreay, D. C., Oessner, M. A. W., Ubin, M. A. R., et al. (1999) · Cited by 1,116 · see citing works

An improved zinc-finger nuclease architecture for highly specific genome editing

Miller, J. C., Holmes, M. C., Wang, J., Guschin, D. Y., Lee, Y.-L., Rupniewski, I., Beausejour, C. M., Waite, A. J., Wang, N. S., Kim, K. A., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1319 · Cited by 1,051 · see citing works

Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases

Perez, E. E., Wang, J., Miller, J. C., Jouvenot, Y., Kim, K. A., Liu, O., Wang, N., Lee, G., Bartsevich, V. V., Lee, Y.-L., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1410 · Cited by 999 · see citing works

Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli

Galibert, F., Mandart, E., Fitoussi, F., Tiollais, P., & Charnay, P. (1979) · Nature · doi:10.1038/281646a0 · Cited by 980 · see citing works

Chimeric nucleases stimulate gene targeting in human cells

Porteus, M. H., & Baltimore, D. (2003) · Science · doi:10.1126/science.1078395 · Cited by 741 · see citing works

Rapid “Open-Source” Engineering of Customized Zinc-Finger Nucleases for Highly Efficient Gene Modification

Maeder, M. L., Thibodeau-Beganny, S., Osiak, A., Wright, D. A., Anthony, R. M., Eichtinger, M., Jiang, T., Foley, J. E., Winfrey, R. J., Townsend, J. A., et al. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.06.016 · Cited by 708 · see citing works

Stimulation of Homologous Recombination through Targeted Cleavage by Chimeric Nucleases

Bibikova, M. V., Carroll, D., Segal, D. J., Trautman, J. K., Smith, J., Kim, Y., & Chandrasegaran, S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.1.289-297.2001 · Cited by 614 · see citing works

Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases

Szczepek, M., Brondani, V., Büchel, J., Serrano, L., Segal, D. J., & Cathomen, T. (2007) · Nature Biotechnology · doi:10.1038/nbt1317 · Cited by 501 · see citing works

Unexpected failure rates for modular assembly of engineered zinc fingers

Ramirez, C. L., Foley, J. E., Wright, D. A., Müller-Lerch, F., Rahman, S. H., Cornu, T. I., Winfrey, R. J., Sander, J. D., Fu, F., Townsend, J. A., et al. (2008) · Nature Methods · doi:10.1038/nmeth0508-374 · Cited by 426 · see citing works

Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains

Smith, J. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.17.3361 · Cited by 425 · see citing works

Zif268 protein–DNA complex refined at 1.6å: a model system for understanding zinc finger–DNA interactions

Elrod-Erickson, M., Rould, M. A., Nekludova, L., & Pabo, C. O. (1996) · Structure · doi:10.1016/s0969-2126(96)00125-6 · Cited by 421 · see citing works

Toward controlling gene expression at will: Selection and design of zinc finger domains recognizing each of the 5′-GNN-3′ DNA target sequences

Segal, D. J., Dreier, B., Beerli, R. R., & Barbas, C. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2758 · Cited by 420 · see citing works

Zinc-finger Nucleases: The Next Generation Emerges.

Cathomen, T., & Joung, J. (2008) · Molecular Therapy · doi:10.1038/mt.2008.114 · Cited by 361 · see citing works

Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases

Santiago, Y., Chan, E. M., Liu, P., Orlando, S., Zhang, L., Urnov, F. D., Holmes, M. C., Guschin, D. Y., Waite, A. J., Miller, J. C., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800940105 · Cited by 358 · see citing works

A bacterial two-hybrid selection system for studying protein–DNA and protein–protein interactions

Joung, J. K., Ramm, E. I., & Pabo, C. O. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.110149297 · Cited by 357 · see citing works

Development of Zinc Finger Domains for Recognition of the 5′-ANN-3′ Family of DNA Sequences and Their Use in the Construction of Artificial Transcription Factors

Dreier, B., Beerli, R. R., Segal, D. J., Flippin, J. D., & Barbas, C. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102604200 · Cited by 329 · see citing works

Toward a code for the interactions of zinc fingers with DNA: selection of randomized fingers displayed on phage.

Choo, Y., & Klug, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11163 · Cited by 322 · see citing works

Selection of DNA binding sites for zinc fingers using rationally randomized DNA reveals coded interactions.

Choo, Y., & Klug, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11168 · Cited by 287 · see citing works

DNA-binding Specificity Is a Major Determinant of the Activity and Toxicity of Zinc-finger Nucleases

Cornu, T. I., Thibodeau-Beganny, S., Guhl, E., Alwin, S., Eichtinger, M., Joung, J. K., & Cathomen, T. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300357 · Cited by 228 · see citing works

Progress and prospects: Zinc-finger nucleases as gene therapy agents

Carroll, D. (2008) · Gene Therapy · doi:10.1038/gt.2008.145 · Cited by 225 · see citing works

In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway

Wu, T., Coates, L. C., Aldrics, C. E., Summers, J. W., & Mason, W. S. (1990) · Virology · doi:10.1016/0042-6822(90)90206-7 · Cited by 221 · see citing works

HEPATITIS B VIRUS AND HEPATOCELLULAR CARCINOMA

MacSween, R. N. M. (1979) · Proceedings in life sciences · doi:10.1007/978-3-642-71350-7_11 · Cited by 219 · see citing works

Chromosomal translocations induced at specified loci in human stem cells

Brunet, E., Simsek, D., Tomishima, M. J., DeKelver, R. C., Choi, V. M., Gregory, P. D., Urnov, F. D., Weinstock, D. M., & Jasin, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902076106 · Cited by 206 · see citing works

Mammalian gene targeting with designed zinc finger nucleases

Porteus, M. H. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.08.003 · Cited by 180 · see citing works

Synthetic Zinc Finger Transcription Factor Action at an Endogenous Chromosomal Site

Zhang, L., Spratt, S. K., Liu, Q., Johnstone, B. H., Qi, H., Raschke, E. E., Jamieson, A. C., Rebar, E. J., Wolffe, A. P., & Case, C. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005341200 · Cited by 180 · see citing works

Development of Zinc Finger Domains for Recognition of the 5′-CNN-3′ Family DNA Sequences and Their Use in the Construction of Artificial Transcription Factors

Dreier, B., Fuller, R. P., Segal, D. J., Lund, C. V., Blancafort, P., Huber, A., Koksch, B., & Barbas, C. F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506654200 · Cited by 171 · see citing works

Validated Zinc Finger Protein Designs for All 16 GNN DNA Triplet Targets

Liu, Q., Xia, Z., & Case, C. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110669200 · Cited by 164 · see citing works

Improved DNA binding specificity from polyzinc finger peptides by using strings of two-finger units

Moore, M. J. B., Klug, A., & Choo, Y. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1437 · Cited by 162 · see citing works

Highly specific zinc finger proteins obtained by directed domain shuffling and cell-based selection

Hurt, J. A., Thibodeau, S. A., Hirsh, A. S., Pabo, C. O., & Joung, J. K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135381100 · Cited by 146 · see citing works

Expanding or Restricting the Target Site Repertoire of Zinc-finger Nucleases: The Inter-domain Linker as a Major Determinant of Target Site Selectivity

Händel, E.-M., Alwin, S., & Cathomen, T. (2008) · Molecular Therapy · doi:10.1038/mt.2008.233 · Cited by 138 · see citing works

Comprehensive DNA Recognition through Concerted Interactions from Adjacent Zinc Fingers

Isalan, M., Klug, A., & Choo, Y. (1998) · Biochemistry · doi:10.1021/bi981358z · Cited by 123 · see citing works

Comparison of Zinc Finger Nucleases for Use in Gene Targeting in Mammalian Cells

Pruett‐Miller, S. M., Connelly, J. P., Maeder, M. L., Joung, J. K., & Porteus, M. H. (2008) · Molecular Therapy · doi:10.1038/mt.2008.20 · Cited by 118 · see citing works

A detailed study of the substrate specificity of a chimeric restriction enzyme

Smith, J., Berg, J. M., & Chandrasegaran, S. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.2.674 · Cited by 107 · see citing works

Zinc Finger Proteins Designed To Specifically Target Duck Hepatitis B Virus Covalently Closed Circular DNA Inhibit Viral Transcription in Tissue Culture

Zimmerman, K. A., Fischer, K. P., Joyce, M., & Tyrrell, D. L. (2008) · Journal of Virology · doi:10.1128/jvi.00366-08 · Cited by 90 · see citing works

Hepatitis B virus and hepatocellular carcinoma

Bruix, J., & Llovet, J. M. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00140-5 · Cited by 88 · see citing works

Zinc Finger Database (ZiFDB): a repository for information on C2H2 zinc fingers and engineered zinc-finger arrays

Fu, F., Sander, J. D., Maeder, M., Thibodeau-Beganny, S., Joung, J. K., Dobbs, D. L., Miller, L., & Voytas, D. F. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn606 · Cited by 84 · see citing works

Interferon in the management of chronic hepatitis B

Perrillo, R. P. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01316785 · Cited by 84 · see citing works

Inhibition of herpes simplex virus 1 gene expression by designer zinc-finger transcription factors

Papworth, M. A., Moore, M., Isalan, M., Minczuk, M. A., Choo, Y., & Klug, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252773399 · Cited by 76 · see citing works

Rational Design Leads to More Potent RNA Interference Against Hepatitis B Virus: Factors Effecting Silencing Efficiency

Keck, K., Volper, E. M., Spengler, R. M., Long, D., Chan, C. Y., Ding, Y., & McCaffrey, A. P. (2008) · Molecular Therapy · doi:10.1038/mt.2008.273 · Cited by 40 · see citing works

A transgenic mouse lineage useful for testing antivirals targeting hepatitis B virus

Marion, P. L., Salazar, F. H., Liittschwager, K., Bordier, B. B., Seeger, C., Winters, M. A., Cooper, A. D., & Cullen, J. M. (2003) · Elsevier eBooks · doi:10.1016/b978-044450986-4/50069-2 · Cited by 31 · see citing works

Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects

Li, H., Yang, Y., Hong, W., Huang, M., Wu, M., & Zhao, X. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0089-y · Cited by 1,771 · see citing works

Therapeutic genome editing: prospects and challenges

Cox, D. B. T., Platt, R. J., & Zhang, F. (2015) · Nature Medicine · doi:10.1038/nm.3793 · Cited by 1,336 · see citing works

HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B

Nassal, M. (2015) · Gut · doi:10.1136/gutjnl-2015-309809 · Cited by 906 · see citing works

Genome-editing Technologies for Gene and Cell Therapy

Maeder, M. L., & Gersbach, C. A. (2016) · Molecular Therapy · doi:10.1038/mt.2016.10 · Cited by 722 · see citing works

Genome Engineering with Targetable Nucleases

Carroll, D. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035418 · Cited by 541 · see citing works

Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection

Pattanayak, V., Ramirez, C. L., Joung, J. K., & Liu, D. R. (2011) · Nature Methods · doi:10.1038/nmeth.1670 · Cited by 453 · see citing works

Meganucleases and Other Tools for Targeted Genome Engineering: Perspectives and Challenges for Gene Therapy

Silva, G., Poirot, L., Galetto, R., Smith, J. N. P., Montoya, G., Duchateau, P. N., & Pâques, F. (2011) · Current Gene Therapy · doi:10.2174/156652311794520111 · Cited by 413 · see citing works

The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo

Lin, S.-R., Yang, H.-C., Kuo, Y.-T., Liu, C.-J., Yang, T.-Y., Sung, K.-C., Lin, Y.-Y., Wang, H.-Y., Wang, C.-C., Shen, Y.-C., et al. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.38 · Cited by 386 · see citing works

Targeting Hepatitis B Virus With CRISPR/Cas9

Seeger, C., & Sohn, J. A. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.68 · Cited by 294 · see citing works

Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure

Zeisel, M. B., Lucifora, J., Mason, W. S., Sureau, C., Beck, J., Levrero, M., Kann, M., Knolle, P. A., Benkirane, M., Durantel, D., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-308943 · Cited by 277 · see citing works

Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities

Gish, R. G., Given, B. D., Lai, C., LOCARNINI, S. A., Lau, J. Y. N., Lewis, D. L., & Schluep, T. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.06.008 · Cited by 257 · see citing works

Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication

Dong, C., Qu, L., Wang, H., Wei, L., Dong, Y., & Xiong, S. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.03.015 · Cited by 245 · see citing works

Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases

Bloom, K., Ely, A., Mussolino, C., Cathomen, T., & Arbuthnot, P. (2013) · Molecular Therapy · doi:10.1038/mt.2013.170 · Cited by 217 · see citing works

Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential

Xia, Y., & Guo, H. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104824 · Cited by 198 · see citing works

Attacking hepatitis B virus cccDNA – The holy grail to hepatitis B cure

Lucifora, J., & Protzer, U. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.009 · Cited by 196 · see citing works

Hepatitis B virus persistence and reactivation

Shi, Y., & Zheng, M. (2020) · BMJ · doi:10.1136/bmj.m2200 · Cited by 191 · see citing works

Engineered zinc finger nickases induce homology-directed repair with reduced mutagenic effects

Ramirez, C. L., Certo, M. T., Mussolino, C., Goodwin, M. J., Cradick, T. J., McCaffrey, A. P., Cathomen, T., Scharenberg, A. M., & Joung, J. K. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks179 · Cited by 174 · see citing works

Covalently closed circular DNA: The ultimate therapeutic target for curing HBV infections

Martínez, M. G., Boyd, A. C., Combe, E., Testoni, B., & Zoulim, F. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.05.013 · Cited by 166 · see citing works

An efficient antiviral strategy for targeting hepatitis B virus genome using transcription activator-like effector nucleases

Chen, J., Zhang, W., Lin, J., Wang, F., Wu, M., Chen, C., Zheng, Y., Peng, X., Li, J., & Yuan, Z. (2014) · Molecular Therapy · doi:10.1038/mt.2013.212 · Cited by 159 · see citing works

Getting to HBV cure: The promising paths forward

Fung, S., Choi, H. S. J., Gehring, A. J., & Janssen, H. L. A. (2022) · Hepatology · doi:10.1002/hep.32314 · Cited by 158 · see citing works

Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance

Yang, H., & Kao, J. (2014) · Emerging Microbes & Infections · doi:10.1038/emi.2014.64 · Cited by 142 · see citing works

Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9

LaFountaine, J. S., Fathe, K., & Smyth, H. D. C. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.08.029 · Cited by 137 · see citing works

Removal of Integrated Hepatitis B Virus DNA Using CRISPR-Cas9

Li, H., Sheng, C., Wang, S., Yang, L., Liang, Y., Huang, Y., Liu, H., Li, P., Yang, C., Yang, X., et al. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00091 · Cited by 131 · see citing works

Genome Engineering at the Dawn of the Golden Age

Segal, D. J., & Meckler, J. F. (2013) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091212-153435 · Cited by 125 · see citing works

Therapeutic gene editing: delivery and regulatory perspectives

Shim, G., Kim, D., Park, G. T., Jin, H., Suh, S., & Oh, Y. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.2 · Cited by 121 · see citing works

AAV-Mediated Delivery of Zinc Finger Nucleases Targeting Hepatitis B Virus Inhibits Active Replication

Weber, N. D., Stone, D., Sedlak, R. H., Feelixge, H. S. D. S., Roychoudhury, P., Schiffer, J. T., Aubert, M., & Jerome, K. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097579 · Cited by 118 · see citing works

Engineering Plant Disease Resistance Based on TAL Effectors

Schornack, S., Moscou, M., Ward, E. R., & Horvath, D. M. (2013) · Annual Review of Phytopathology · doi:10.1146/annurev-phyto-082712-102255 · Cited by 118 · see citing works

Genome Editing: A New Approach to Human Therapeutics

Porteus, M. H. (2015) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124454 · Cited by 116 · see citing works

CRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X

Karimova, M., Beschorner, N., Dammermann, W., Chemnitz, J., Indenbirken, D., Bockmann, J., Grundhoff, A. T., Lüth, S., Buchholz, F., Wiesch, J. S. Z., et al. (2015) · Scientific Reports · doi:10.1038/srep13734 · Cited by 116 · see citing works

Targeted DNA Mutagenesis for the Cure of Chronic Viral Infections

Schiffer, J. T., Aubert, M., Weber, N. D., Mintzer, E., Stone, D., & Jerome, K. R. (2012) · Journal of Virology · doi:10.1128/jvi.00052-12 · Cited by 111 · see citing works

The I-CreI meganuclease and its engineered derivatives: applications from cell modification to gene therapy

Arnould, S., Delenda, C., Grizot, S., Desseaux, C., Pâques, F., Silva, G. H., & Smith, J. (2010) · Protein Engineering Design and Selection · doi:10.1093/protein/gzq083 · Cited by 112 · see citing works

Non-viral delivery of genome-editing nucleases for gene therapy

Wang, M., Glass, Z., & Xu, Q. (2016) · Gene Therapy · doi:10.1038/gt.2016.72 · Cited by 110 · see citing works

Zinc-Finger Nuclease Based Genome Surgery: Its All About Specificity

Händel, E.-M., & Cathomen, T. (2011) · Current Gene Therapy · doi:10.2174/156652311794520120 · Cited by 101 · see citing works

CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice

Stone, D., Long, K. R., Loprieno, M. A., Feelixge, H. S. D. S., Kenkel, E. J., Liley, R. M., Rapp, S., Roychoudhury, P., Nguyen, T., Stensland, L., et al. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.11.014 · Cited by 97 · see citing works

Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation

Wei, Z., Zhang, Y., Ke, C., Chen, H., Ren, P., He, Y., Hu, P., Ma, D.-Q., Luo, J. D., & Meng, Z. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i34.6252 · Cited by 96 · see citing works

Engineering nucleases for gene targeting: safety and regulatory considerations

Pauwels, K., Podevin, N., Breyer, D., Carroll, D., & Herman, P. (2013) · New Biotechnology · doi:10.1016/j.nbt.2013.07.001 · Cited by 93 · see citing works

Correction of the ΔF508 Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator Gene by Zinc-Finger Nuclease Homology-Directed Repair

Lee, C. M., Flynn, R., Hollywood, J. A., Scallan, M. F., & Harrison, P. T. (2012) · BioResearch open access · doi:10.1089/biores.2012.0218 · Cited by 84 · see citing works

Newer Gene Editing Technologies toward HIV Gene Therapy

Manjunath, N., Yi, G., Dang, Y., & Shankar, P. (2013) · Viruses · doi:10.3390/v5112748 · Cited by 77 · see citing works

Towards HBV curative therapies

Schinazi, R. F., Ehteshami, M., Bassit, L., & Asselah, T. (2018) · Liver International · doi:10.1111/liv.13656 · Cited by 76 · see citing works

Perspectives and control of hepatitis B virus infection in Taiwan

Lin, C., & Kao, J. (2015) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2015.06.003 · Cited by 74 · see citing works

Gene Therapy for Chronic HBV—Can We Eliminate cccDNA?

Bloom, K. M., Maepa, M. B., Ely, A., & Arbuthnot, P. B. (2018) · Genes · doi:10.3390/genes9040207 · Cited by 74 · see citing works

HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure

Moini, M., & Fung, S. K. (2022) · Viruses · doi:10.3390/v14040657 · Cited by 73 · see citing works

Advances with using CRISPR/Cas-mediated gene editing to treat infections with hepatitis B virus and hepatitis C virus

Moyo, B., Bloom, K. M., Scott, T. A., Ely, A., & Arbuthnot, P. B. (2017) · Virus Research · doi:10.1016/j.virusres.2017.01.003 · Cited by 70 · see citing works

Insights into Hepatitis B Virus DNA Integration-55 Years after Virus Discovery

Zhao, K., Liu, A., & Xia, Y. (2020) · The Innovation · doi:10.1016/j.xinn.2020.100034 · Cited by 71 · see citing works

Highly multiplexed CRISPR‐Cas9‐nuclease and Cas9‐nickase vectors for inactivation of hepatitis B virus

Sakuma, T., Masaki, K., Abe‐Chayama, H., Mochida, K., Yamamoto, T., & Chayama, K. (2016) · Genes to Cells · doi:10.1111/gtc.12437 · Cited by 70 · see citing works

Meganuclease-mediated Inhibition of HSV1 Infection in Cultured Cells

Grosse, S. M., Huot, N., Mahiet, C., Arnould, S., Barradeau, S., Clerre, D. L., Chion-Sotinel, I., Jacqmarcq, C., Chapellier, B., Ergani, A., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2010.302 · Cited by 70 · see citing works

Towards a new era in medicine: therapeutic genome editing

Porteus, M. H. (2015) · Genome Biology · doi:10.1186/s13059-015-0859-y · Cited by 69 · see citing works

New Approaches to the Treatment of Chronic Hepatitis B

Alexopoulou, A. A., Vasilieva, L., & Karayiannis, P. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103187 · Cited by 68 · see citing works

Gene editing and its applications in biomedicine

Li, G., Li, X., Zhuang, S., Wang, L., Zhu, Y., Chen, Y., Sun, W. C., Wu, Z., Zhou, Z. L., Chen, J., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-021-2057-0 · Cited by 65 · see citing works

Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus

Kim, S. W., Yoon, J. S., Lee, M., & Cho, Y. (2021) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2021.0093 · Cited by 66 · see citing works

CRISPR/Cas9 produces anti-hepatitis B virus effect in hepatoma cells and transgenic mouse

Zhu, W., Xie, K., Xu, Y., Wang, L., Chen, K., Zhang, L., & Fang, J. (2016) · Virus Research · doi:10.1016/j.virusres.2016.04.003 · Cited by 66 · see citing works

Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment

Kennedy, E. M., & Cullen, B. R. (2015) · Virology · doi:10.1016/j.virol.2015.02.024 · Cited by 64 · see citing works

Zinc Finger Nucleases Targeting the Human Papillomavirus E7 Oncogene Induce E7 Disruption and a Transformed Phenotype in HPV16/18-Positive Cervical Cancer Cells

Ding, W., Hu, Z., Zhu, D., Jiang, X., Yu, L., Wang, X., Zhang, C., Wang, L., Ji, T., Li, K., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0250 · Cited by 64 · see citing works

ssAAVs containing cassettes encoding SaCas9 and guides targeting hepatitis B virus inactivate replication of the virus in cultured cells

Scott, T. A., Moyo, B., Nicholson, S., Maepa, M. B., Watashi, K., Ely, A., Weinberg, M. S., & Arbuthnot, P. B. (2017) · Scientific Reports · doi:10.1038/s41598-017-07642-6 · Cited by 65 · see citing works

Rosmarinic acid is a novel inhibitor for Hepatitis B virus replication targeting viral epsilon RNA-polymerase interaction

Tsukamoto, Y., Ikeda, S., Uwai, K., Taguchi, R., Chayama, K., Sakaguchi, T., Narita, R., Yao, W.-L., Takeuchi, F., Otakaki, Y., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197664 · Cited by 61 · see citing works

Curcumin and Photobiomodulation in Chronic Viral Hepatitis and Hepatocellular Carcinoma

Ailioaie, L. M., & Litscher, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197150 · Cited by 61 · see citing works

HBV Genome and Life Cycle

Wang, J., Huang, H., Liu, Y., Chen, R., Yan, Y., Shu, S., Xi, J., Zou, J., Yu, G., Feng, X., et al. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9151-4_2 · Cited by 60 · see citing works

Nanobiomaterial vectors for improving gene editing and gene therapy

Hu, S. W., Ding, T., Tang, H., Guo, H., Cui, W., & Shu, Y. (2023) · Materials Today · doi:10.1016/j.mattod.2023.04.011 · Cited by 58 · see citing works

The gRNA-miRNA-gRNA Ternary Cassette Combining CRISPR/Cas9 with RNAi Approach Strongly Inhibits Hepatitis B Virus Replication

Wang, J., Chen, R., Zhang, R., Ding, S., Zhang, T., Yuan, Q., Guan, G., Chen, X., Zhang, T., Zhuang, H., et al. (2017) · Theranostics · doi:10.7150/thno.18114 · Cited by 56 · see citing works

Targeted gene disruption to cure HIV

Stone, D., Kiem, H.-P., & Jerome, K. R. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32835f736c · Cited by 55 · see citing works

The potential and challenges of CRISPR-Cas in eradication of hepatitis B virus covalently closed circular DNA

Yang, H., & Chen, P. (2017) · Virus Research · doi:10.1016/j.virusres.2017.06.010 · Cited by 54 · see citing works

Strategies to Eliminate HBV Infection

Kapoor, R., & Kottilil, S. (2014) · Future Virology · doi:10.2217/fvl.14.36 · Cited by 54 · see citing works

Recent advances in targeted genome engineering in mammalian systems

Sun, N., Abil, Z., & Zhao, H. (2012) · Biotechnology Journal · doi:10.1002/biot.201200038 · Cited by 52 · see citing works

Review article: novel therapies for hepatitis B virus cure – advances and perspectives

Lin, C., & Kao, J. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13694 · Cited by 52 · see citing works

Hepatitis B

Spyrou, E., Smith, C. I., & Ghany, M. G. (2020) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2020.01.003 · Cited by 51 · see citing works

Successful Targeting and Disruption of an Integrated Reporter Lentivirus Using the Engineered Homing Endonuclease Y2 I-AniI

Aubert, M., Ryu, B. Y., Banks, L., Rawlings, D. J., Scharenberg, A. M., & Jerome, K. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016825 · Cited by 48 · see citing works

Toward a new era of hepatitis B virus therapeutics: The pursuit of a functional cure

Tsounis, E. P., Tourkochristou, E., Mouzaki, Α., & Triantos, C. K. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i21.2727 · Cited by 46 · see citing works

Predictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes: a mathematical modeling approach

Schiffer, J. T., Swan, D. A., Stone, D., & Jerome, K. R. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003131 · Cited by 44 · see citing works

Genome editing and the next generation of antiviral therapy

Stone, D., Niyonzima, N., & Jerome, K. R. (2016) · Human Genetics · doi:10.1007/s00439-016-1686-2 · Cited by 43 · see citing works

Recent Advances in Hepatitis B Treatment

Prifti, G., Moianos, D., Giannakopoulou, E., Pardali, V., Tavis, J. E., & Zoidis, G. (2021) · Pharmaceuticals · doi:10.3390/ph14050417 · Cited by 44 · see citing works

General practice - workforce gaps now and in 2020.

Harrison, C. M., & Britt, H. C. (2011) · PubMed · Cited by 44 · see citing works

Whole-genome sequencing of matched primary and metastatic hepatocellular carcinomas

Ouyang, L., Lee, J., Park, C.-K., Mao, M., Shi, Y., Gong, Z., Zheng, H., Li, Y., Zhao, Y., Wang, G., et al. (2014) · BMC Medical Genomics · doi:10.1186/1755-8794-7-2 · Cited by 42 · see citing works

Hepatitis B virus: new therapeutic perspectives

Lin, C., Yang, H., & Kao, J. (2016) · Liver International · doi:10.1111/liv.13003 · Cited by 41 · see citing works

Progress With Developing Use of Gene Editing To Cure Chronic Infection With Hepatitis B Virus

Ely, A., Moyo, B., & Arbuthnot, P. B. (2016) · Molecular Therapy · doi:10.1038/mt.2016.43 · Cited by 41 · see citing works

Current concepts on immunopathogenesis of hepatitis B virus infection

Peeridogaheh, H., Meshkat, Z., Habibzadeh, S., Arzanlou, M., Mohammadshahi, J., Rostami, S., Gerayli, S., & Teimourpour, R. (2017) · Virus Research · doi:10.1016/j.virusres.2017.12.007 · Cited by 41 · see citing works

Progress and Prospects of Anti-HBV Gene Therapy Development

Maepa, M. B., Roelofse, I., Ely, A., & Arbuthnot, P. B. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160817589 · Cited by 39 · see citing works

Virus–host interplay in hepatitis B virus infection and epigenetic treatment strategies

Hensel, K. O., Rendón, J., Navas, M. C., Rots, M. G., & Postberg, J. (2017) · FEBS Journal · doi:10.1111/febs.14094 · Cited by 39 · see citing works

Application of CRISPR/Cas9 Technology to HBV

Lin, G., Zhang, K., & Li, J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125950 · Cited by 40 · see citing works

HBV cccDNA and Its Potential as a Therapeutic Target

Zhu, A., Liao, X., Li, S., Zhao, H., Chen, L., Xu, M., & Duan, X. (2019) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2018.00054 · Cited by 37 · see citing works

Gene Editing Technologies to Target HBV cccDNA

Martínez, M. G., Smekalova, E. M., Combe, E., Gregoire, F. M., Zoulim, F., & Testoni, B. (2022) · Viruses · doi:10.3390/v14122654 · Cited by 36 · see citing works

HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis

Nevola, R., Beccia, D., Rosato, V., Ruocco, R., Mastrocinque, D., Villani, A., Perillo, P., Imbriani, S., Femine, A. D., Criscuolo, L., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087651 · Cited by 37 · see citing works

Treatment of Hepatitis B Virus: An Update

Ward, H., Tang, L., Poonia, B., & Kottilil, S. (2016) · Future Microbiology · doi:10.2217/fmb-2016-0128 · Cited by 32 · see citing works

Chronic hepatitis B: New potential therapeutic drugs target

Leowattana, W., & Leowattana, T. (2022) · World Journal of Virology · doi:10.5501/wjv.v11.i1.57 · Cited by 30 · see citing works

Eliminating cccDNA to cure hepatitis B virus infection

Zoulim, F., & Testoni, B. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.01.017 · Cited by 29 · see citing works

Zinc finger nucleases: Tailor-made for gene therapy

Chou, S.-T., Leng, Q., & Mixson, A. J. (2012) · Drugs of the Future · doi:10.1358/dof.2012.37.3.1779022 · Cited by 29 · see citing works

Viral life cycle of hepatitis B virus: Host factors and druggable targets

Morikawa, K., Suda, G., & Sakamoto, N. (2016) · Hepatology Research · doi:10.1111/hepr.12650 · Cited by 29 · see citing works

The impact of integrated hepatitis B virus DNA on oncogenesis and antiviral therapy

Zhang, M., Chen, H., Liu, H., & Tang, H. (2024) · Biomarker Research · doi:10.1186/s40364-024-00611-y · Cited by 28 · see citing works

DNA cleavage enzymes for treatment of persistent viral infections: Recent advances and the pathway forward

Weber, N. D., Aubert, M., Dang, C. H., Stone, D., & Jerome, K. R. (2014) · Virology · doi:10.1016/j.virol.2013.12.037 · Cited by 28 · see citing works

Pharmacokinetics and pharmacodynamics of pegylated interferon for the treatment of hepatitis B

Yeh, M., Huang, J., Dai, C., Yu, M., & Chuang, W. (2019) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2019.1678584 · Cited by 28 · see citing works

Viral hepatitis: Innovations and expectations

Leoni, S., Casabianca, A., Biagioni, B., & Serio, I. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i5.517 · Cited by 28 · see citing works

Hepatitis B Core-Related Antigen and New Therapies for Hepatitis B

Watanabe, T., Inoue, T., & Tanaka, Y. (2021) · Microorganisms · doi:10.3390/microorganisms9102083 · Cited by 26 · see citing works

The potential of HBV cure: an overview of CRISPR-mediated HBV gene disruption

Yao, Z. Q., Schank, M., Zhao, J., Gazzar, M. E., Wang, L., Zhang, Y., Hill, A. C., Banik, P., Pyburn, J. S., & Moorman, J. P. (2024) · Frontiers in Genome Editing · doi:10.3389/fgeed.2024.1467449 · Cited by 28 · see citing works

Unveiling the potential of gene editing techniques in revolutionizing Cancer treatment: A comprehensive overview

Garg, P., Singhal, G., Pareek, S., Kulkarni, P., Horne, D., Nath, A., Salgia, R., & Singhal, S. S. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189233 · Cited by 23 · see citing works

Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA

Ahmed, M., Wang, F., Levin, A., Le, C., Eltayebi, Y., Houghton, M., Tyrrell, D. L., & Barakat, K. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.01.008 · Cited by 23 · see citing works

Advanced Therapeutics, Vaccinations, and Precision Medicine in the Treatment and Management of Chronic Hepatitis B Viral Infections; Where Are We and Where Are We Going?

Duraisamy, G. S., Bhosale, D. S., Lipenská, I., Huvarová, I., Růžek, D., Windisch, M. P., & Miller, A. D. (2020) · Viruses · doi:10.3390/v12090998 · Cited by 23 · see citing works

Immune balance in Hepatitis B Infection: Present and Future Therapies

Vyas, A. K., Jindal, A., Hissar, S. S., Ramakrishna, G., & Trehanpati, N. (2017) · Scandinavian Journal of Immunology · doi:10.1111/sji.12553 · Cited by 22 · see citing works

Proviral HIV-genome-wide and pol-gene specific zinc finger nucleases: Usability for targeted HIV gene therapy

Wayengera, M. (2011) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-8-26 · Cited by 21 · see citing works

Genome editing-based HIV therapies

Gu, W.-G. (2015) · Trends in biotechnology · doi:10.1016/j.tibtech.2014.12.006 · Cited by 20 · see citing works

CPP-ZFN: A potential DNA-targeting anti-malarial drug

Nain, V., Sahi, S., & Verma, A. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-258 · Cited by 20 · see citing works

Gene-Editing and RNA Interference in Treating Hepatitis B: A Review

Kasianchuk, N., Dobrowolska, K., Harkava, S., Bretcan, A., Zarębska‐Michaluk, D., Jaroszewicz, J., Flisiak, R., & Rzymski, P. (2023) · Viruses · doi:10.3390/v15122395 · Cited by 19 · see citing works

Designing zinc finger nucleases that specifically cleave Hepatitis B viral DNA

Cradick, T. J. (2009) · doi:10.17077/etd.484mzmj5

407. Zinc-Finger Nucleases Targeting Hepatitis B Virus Genomic DNA

(2008) · Molecular Therapy · doi:10.1016/s1525-0016(16)39810-0

AAV-Mediated Delivery of Zinc Finger Nucleases Targeting Hepatitis B Virus Inhibits Active Replication

Weber, N. D., Stone, D., Sedlak, R. H., Feelixge, H. S. D. S., Roychoudhury, P., Schiffer, J. T., Aubert, M., & Jerome, K. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097579 · Cited by 118 · see citing works

580. Zinc-Finger Nucleases Inactivating Hepatitis B Virus Genomic DNA

(2007) · Molecular Therapy · doi:10.1016/s1525-0016(16)44786-6

Using designed zinc finger proteins to inhibit hepatitis B virus transcription in tissue culture

Miller, K. L. (2012) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3hh8q